FGF8 induces therapy resistance in neoadjuvantly radiated rectal cancer

ConclusionThe results of this study suggest that FGF8 and Survivin contribute to radiation resistance in rectal cancer and may serve as markers to select patients who may not benefit from neoadjuvant radiotherapy.

Source: Journal of Cancer Research and Clinical Oncology - October 1, 2018 Category: Cancer & Oncology Source Type: research